Lawrence Erik Kurzius Acquires 10,000 Shares of Cooper Companies (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) Director Lawrence Kurzius acquired 10,000 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The stock was bought at an average price of $53.91 per share, with a total value of $539,100.00. Following the transaction, the director directly owned 21,099 shares in the company, valued at $1,137,447.09. The trade was a 90.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Cooper Companies Trading Down 1.8%

NASDAQ:COO traded down $0.95 during trading hours on Tuesday, hitting $53.27. 4,408,999 shares of the stock were exchanged, compared to its average volume of 2,501,526. The company has a market capitalization of $10.13 billion, a P/E ratio of 18.18, a price-to-earnings-growth ratio of 2.19 and a beta of 0.82. The company has a quick ratio of 0.73, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The company’s 50 day moving average is $71.25 and its two-hundred day moving average is $69.40. The Cooper Companies, Inc. has a twelve month low of $51.01 and a twelve month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.12 by $0.03. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the firm earned $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.

Cooper Companies announced that its Board of Directors has authorized a stock buyback program on Wednesday, September 9th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the medical device company to repurchase up to 22.7% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on COO. Wall Street Zen lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday. Mizuho set a $75.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a report on Thursday, September 10th. Needham & Company LLC reduced their price objective on shares of Cooper Companies from $86.00 to $73.00 and set a “buy” rating on the stock in a research note on Thursday, September 10th. JPMorgan Chase & Co. lowered their target price on shares of Cooper Companies from $71.00 to $58.00 and set a “neutral” rating for the company in a report on Thursday, September 10th. Finally, Zacks Research lowered shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a report on Friday. Five analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $71.47.

Institutional Trading of Cooper Companies

Institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. bought a new position in Cooper Companies during the 2nd quarter worth approximately $1,077,762,000. Generation Investment Management LLP bought a new stake in Cooper Companies in the second quarter valued at approximately $356,304,000. Franklin Resources Inc. raised its holdings in Cooper Companies by 108.2% in the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock worth $329,646,000 after purchasing an additional 2,089,763 shares during the period. Jupiter Topco LLC acquired a new stake in Cooper Companies in the second quarter worth $305,074,000. Finally, Diamond Hill Capital Management Inc. boosted its position in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

About Cooper Companies

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.